BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 32878779)

  • 21. Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells.
    Cascioferro S; Petri GL; Parrino B; Carbone D; Funel N; Bergonzini C; Mantini G; Dekker H; Geerke D; Peters GJ; Cirrincione G; Giovannetti E; Diana P
    Eur J Med Chem; 2020 Mar; 189():112088. PubMed ID: 32007666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
    Kumar S; Gopalakrishnan V; Hegde M; Rana V; Dhepe SS; Ramareddy SA; Leoni A; Locatelli A; Morigi R; Rambaldi M; Srivastava M; Raghavan SC; Karki SS
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4682-4688. PubMed ID: 25205189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds.
    Romagnoli R; Baraldi PG; Prencipe F; Balzarini J; Liekens S; Estévez F
    Eur J Med Chem; 2015 Aug; 101():205-17. PubMed ID: 26141911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1.
    Giovannetti E; Leon LG; Gómez VE; Zucali PA; Minutolo F; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):643-651. PubMed ID: 27906635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.
    Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC
    Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Imidazo[2,1-
    Li Petri G; Pecoraro C; Randazzo O; Zoppi S; Cascioferro SM; Parrino B; Carbone D; El Hassouni B; Cavazzoni A; Zaffaroni N; Cirrincione G; Diana P; Peters GJ; Giovannetti E
    Anticancer Res; 2020 Sep; 40(9):4913-4919. PubMed ID: 32878779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Cancer Cell Line Based Approach of 1,3,4-thiadiazole and its Fused Ring: A Comprehensive Review.
    Raj V; Rai A; Saha S
    Anticancer Agents Med Chem; 2017; 17(4):500-523. PubMed ID: 27745547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorinated nucleosides as an important class of anticancer and antiviral agents.
    Cavaliere A; Probst KC; Westwell AD; Slusarczyk M
    Future Med Chem; 2017 Oct; 9(15):1809-1833. PubMed ID: 28929804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Possible Strategies for Drug Modification of Gemcitabine and Future Contributions to Personalized Medicine.
    Pereira M; Vale N
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic charisma of imidazo [2,1-b] [1,3,4]-thiadiazole analogues: a patent review.
    Mehra A; Sangwan R; Mehra A; Sharma S; Wadhwa P; Mittal A
    Pharm Pat Anal; 2023 Jul; 12(4):177-191. PubMed ID: 37671908
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.